Bengaluru: Ayurveda medicines cure COVID-19 patients in clinical trial, Govt to take it to next stage
Team Udayavani, Jul 2, 2020, 9:26 AM IST
Bengaluru: A team led by Ayurveda expert Dr. Giridhar Kaje has come up with Ayurvedic medicines and they had conducted a clinical trial on 10 patients. In a breakthrough, all 10 patients have been cured of the disease within 10 days.
Indian Medical Research Organization’s body Clinical Trial Registry of India had permitted Victoria Hospital to conduct Clinical trials using these medicines.
The Ayurveda experts have conducted the clinical trial from June 7 to June 25. It is gathered that all the 10 patients aged between 23 to 65 have been cured in 3 to 9 days and tested negative for COVID-19 in the final test, though the patients were suffering from Diabetes, Blood pressure, Tuberculosis.
The government officials have informed the Rajiv Gandhi Health University chancellor to give a report on this trial to take it forward to the next stage.
The cost of one medicine would be around Rs. 60 to Rs. 180 and in the future days if found beneficial. The government would take a decision on giving these medicines to treating the patients, first and second contacts as a precautionary measure.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Row over candidate intensifies as Cong scrambles to finalise pick in faction-ridden Kolar unit
Told to speak softly, man assaults relative; Case filed
BJP’s Brijesh Chowta to file nomination papers on April 4; discloses assets
M’luru/Udupi: Toll fees to be hiked from Apr 1
Tumakur triple murder case; Mortal remains of victims reach Belthangady
MUST WATCH
Latest Additions
BJP’s Rekha Patra moves SC, women panels against TMC for ‘violation’ of privacy
Nortje will take time to get better after injury lay-off: DC bowling coach Hopes
After Congress, CPI gets I-T dept notice for Rs 11-crore dues: Sources
Row over candidate intensifies as Cong scrambles to finalise pick in faction-ridden Kolar unit
FPIs make remarkable comeback; infuse Rs 2 lakh cr in equities in FY24